F.D.A. Moves to Stop Rogue Clinics From Using Unapproved Stem Cell Therapies

20:01 EDT 9 May 2018 | The New York Times News

The agency is seeking permanent injunctions against companies in Florida and California that are marketing unregulated uses of stem cells.

More From BioPortfolio on "F.D.A. Moves to Stop Rogue Clinics From Using Unapproved Stem Cell Therapies"